researchers used both human samples and mouse models of MS to show that not only does the cytokine signaling between B cells and T cells go awry in MS, but also that B cells of MS patients produce ...

An Australian startup has unveiled the world’s first commercial biologic. Melbourne-based Cortical Labs launched the CL1 at ...

Scaling up biohybrid robots has been difficult due to the weak contractile force of lab-grown muscles, the risk of necrosis in thick muscle tissues, and the challenge of integrating biological ...

We focused on developing fully human scFv CARs for CD19 as a target because CARs with murine scFvs are effective in inducing remissions in patients with relapsed and refractory B-cell malignancies.

Being fruitful, they multiply into a ball of many cells, a shimmering sphere of human potential. Scientists have long dreamed of plucking those naive cells from a young human embryo and coaxing ...

SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results ...